Literature DB >> 23104299

Multiplex real-time PCR (MRT-PCR) for diarrheagenic.

Francesca Barletta1, Theresa J Ochoa, Thomas G Cleary.   

Abstract

Diarrheagenic Escherichia coli strains are important causes of diarrhea in children from the developing world and are now being recognized as emerging enteropathogens in the developed world. Current methods of detection are too expensive and labor-intensive for routine detection of these organisms to be practical. We developed a real-time fluorescence-based multiplex PCR for the detection of all six of the currently recognized classes of diarrheagenic E. coli. The primers were designed to specifically amplify eight different virulence genes in the same reaction: aggR for enteroaggregative E. coli (EAEC), stIa/stIb and lt for enterotoxigenic E. coli (ETEC), eaeA for enteropathogenic E. coli (EPEC), stx1 and stx2 for Shiga toxin-producing E. coli (STEC), ipaH for enteroinvasive E. coli (EIEC), and daaD for diffusely adherent E. coli (DAEC).

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23104299     DOI: 10.1007/978-1-60327-353-4_21

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  9 in total

Review 1.  Pathogenesis of human diffusely adhering Escherichia coli expressing Afa/Dr adhesins (Afa/Dr DAEC): current insights and future challenges.

Authors:  Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

2.  Detection of enteropathogens associated with travelers' diarrhea using a multiplex Luminex-based assay performed on stool samples smeared on Whatman FTA Elute cards.

Authors:  Tahaniyat Lalani; Michele D Tisdale; Jason D Maguire; Chansuda Wongsrichanalai; Mark S Riddle; David R Tribble
Journal:  Diagn Microbiol Infect Dis       Date:  2015-05-27       Impact factor: 2.803

Review 3.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

4.  A two-tube multiplex reverse transcription PCR assay for simultaneous detection of viral and bacterial pathogens of infectious diarrhea.

Authors:  Ji Wang; Ziqian Xu; Peihua Niu; Chen Zhang; Jingyun Zhang; Li Guan; Biao Kan; Zhaojun Duan; Xuejun Ma
Journal:  Biomed Res Int       Date:  2014-03-10       Impact factor: 3.411

5.  Identification and antimicrobial resistance patterns of bacterial enteropathogens from children aged 0-59 months at the University Teaching Hospital, Lusaka, Zambia: a prospective cross sectional study.

Authors:  Harriet Chiyangi; John B Muma; Sydney Malama; Joel Manyahi; Ahmed Abade; Geoffrey Kwenda; Mecky I Matee
Journal:  BMC Infect Dis       Date:  2017-02-02       Impact factor: 3.090

6.  Detection and discrimination of five E. coli pathotypes using a combinatory SYBR® Green qPCR screening system.

Authors:  Elodie Barbau-Piednoir; Sarah Denayer; Nadine Botteldoorn; Katelijne Dierick; Sigrid C J De Keersmaecker; Nancy H Roosens
Journal:  Appl Microbiol Biotechnol       Date:  2018-02-20       Impact factor: 4.813

7.  Virulence gene profiles and molecular genetic characteristics of diarrheagenic Escherichia coli from a hospital in western China.

Authors:  Dan Li; Min Shen; Ying Xu; Chao Liu; Wen Wang; Jinyan Wu; Xianmei Luo; Xu Jia; Yongxin Ma
Journal:  Gut Pathog       Date:  2018-08-17       Impact factor: 4.181

8.  Lactobacillus plantarum BSGP201683 Isolated from Giant Panda Feces Attenuated Inflammation and Improved Gut Microflora in Mice Challenged with Enterotoxigenic Escherichia coli.

Authors:  Qian Liu; Xueqin Ni; Qiang Wang; Zhirong Peng; Lili Niu; Hengsong Wang; Yi Zhou; Hao Sun; Kangcheng Pan; Bo Jing; Dong Zeng
Journal:  Front Microbiol       Date:  2017-09-26       Impact factor: 5.640

9.  Diversity of Virulence Genes in Multidrug Resistant Escherichia coli from a Hospital in Western China.

Authors:  Xue Li; Qi Luo; Xinyu Yu; Yanling Zhang; Xiaoyue Cao; Dan Li
Journal:  Infect Drug Resist       Date:  2019-12-05       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.